Skip to main content
OpenTrials

Clinical trial condition

Stage III Rectal Cancer AJCC v8

Explore clinical trials studying Stage III Rectal Cancer AJCC v8. Study availability and eligibility vary by location and protocol.

22 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Stage III Rectal Cancer AJCC v8 trial results

Active, Not Recruiting

Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation

NCT05610163

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 685 locations
View Trial Details

Related conditions